The Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is gaining momentum as awareness of neurodevelopmental conditions expands, diagnostic practices improve, and treatment options become increasingly diverse. ADHD affects children, adolescents, and adults, with symptoms that may include inattention, hyperactivity, and impulsivity. These symptoms can influence academic performance, workplace productivity, relationships, and everyday functioning, creating a sustained need for effective and accessible treatment.